Potential risks of cardiovascular and cerebrovascular disease and cancer due to cumulative doses received from diagnostic CT scans?

Martin, C. J. and Barnard, M. (2021) Potential risks of cardiovascular and cerebrovascular disease and cancer due to cumulative doses received from diagnostic CT scans? Journal of Radiological Protection, 41(4), pp. 1243-1257. (doi: 10.1088/1361-6498/ac270f) (PMID:34525460)

[img] Text
259417.pdf - Published Version
Available under License Creative Commons Attribution.

705kB

Abstract

Potential risks from radiation exposure on the development of cardiovascular and cerebrovascular disease are indicated by epidemiological studies. Medical exposures give the largest dose to the population from artificial sources, with cumulative doses from multiple CT scans being significant. Data on doses from scans performed on 12 CT scanners in three hospitals over a period of 5½ years, derived using RadimetricsTM software, have been reviewed for 105 757 patients. Data have been downloaded for heart, brain, thyroid, and effective doses, and cumulative doses analysed using ExcelTM spreadsheets. 2.4% of patients having body CT scans received cumulative doses to the heart over 100 mSv, 9% of whom were under 50 years. 9.6% of patients having head CT scans received cumulative doses to the brain over 100 mSv with 0.08% over 500 mSv from whom 41% were under 50 years, but only 1.3% of patients scanned had thyroid/carotid artery doses over 100 mSv. An approximate evaluation of potential risks from exposures of the heart above 100 mSv and brain over 500 mSv for patients under 60 years would suggest that at most only one patient would demonstrate any excess risk from vascular disease resulting from the exposures. 0.67% of patients scanned received effective doses over 100 mSv, in line with results from European studies, with 8.4% being under 50 years. The application of age and sex specific risk coefficients relating to excess cancer incidence suggests that two or three patients with effective doses over 100 mSv and five patients with effective doses between 50 and 100 mSv, from those examined, might develop cancer as a result of exposure. However, this will be an overestimate, since it does not take patients' health into account. Exposure management software can aid in evaluating cumulative doses and identifying individual patients receiving substantial doses from repetitive imaging.

Item Type:Articles
Keywords:Heart dose, brain dose, cumulative effective dose, computed tomography, cardiovascular effects, cerebrovascular effects.
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Martin, Dr Colin
Authors: Martin, C. J., and Barnard, M.
College/School:College of Medical Veterinary and Life Sciences > School of Medicine, Dentistry & Nursing
Journal Name:Journal of Radiological Protection
Publisher:IOP Publishing
ISSN:0952-4746
ISSN (Online):1361-6498
Published Online:24 November 2021
Copyright Holders:Copyright © 2021 The Authors
First Published:First published in Journal of Radiological Protection 41(4): 1243-1257
Publisher Policy:Reproduced under a Creative Commons License

University Staff: Request a correction | Enlighten Editors: Update this record